Legal Representation
Attorney
Auma N. Reggy
USPTO Deadlines
Next Deadline
23 days remaining
Non-Final Action E-Mailed
Due Date
January 23, 2026
Extension Available
Until April 23, 2026
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 16, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 16, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 16, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 23, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 23, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 23, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 23, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 18, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 7, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 7, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 30, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 30, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Healthcare technology, analytics, and business management services for healthcare organizations and manufacturers in the nature of inventory management, financial record-keeping, regulatory compliance, operations optimization, namely, consulting in the field of healthcare operations management, supply chain efficiency, program management for enabling participants to receive software and services in the field of healthcare
Class 039
Distribution services, namely, delivery of pharmaceuticals, medical supplies, healthcare technology products, and health and beauty products
Additional Information
Design Mark
The mark consists of MOMENTIM RX with a flywheel design surrounding the RX.
Classification
International Classes
035
039
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
RX